Idenix Pharmaceuticals to Present at Credit Suisse First Boston's Healthcare Conference

CAMBRIDGE, Mass., Nov. 8  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will present a corporate overview at the upcoming Credit Suisse First Boston Healthcare Conference on Wednesday, November 16, 2005 at 10:30 a.m. at the Arizona Biltmore in Phoenix.

The live and archived webcast of the presentation can be accessed under "Events" in the Idenix Investor Center at http://www.idenix.com/.  The archived replays will be available on the Idenix website for two weeks following the presentations.

About Idenix

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV).  Idenix's headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy.

  Contact:
   Idenix Pharmaceuticals, Inc.
   Teri Dahlman [phone]


DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT: Teri Dahlman of Idenix Pharmaceuticals, Inc., [phone]



Web site:  http://www.idenix.com/

Copyright